Differential stabilization of topoisomerase-II-DNA cleavable complexes by doxorubicin and etoposide in doxorubicin-resistant rat glioblastoma cells

European Journal of Biochemistry

Volumn 245, Issue 2, 1997, Pages 307-315

  Montaudon, Danièle ^a   Pourquier, Philippe ^a   Denois, Françoise ^a   De Tinguy Moreaud, Éliane ^a   Lagarde, Philippe ^a   Robert, Jacques ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Anticancer drug; DNA damage; Drug resistance; Topoisomerase II

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; ETOPOSIDE; VERAPAMIL;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DRUG ACCUMULATION; DRUG RESISTANCE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BINDING; GLIOBLASTOMA; IMMUNOBLOTTING; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR CELL;

ANIMALIA;

EID: 0030942479     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1997.00307.x     Document Type: Article

References (46)

1. Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. D. & Liu, L. F. (1984) Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II, Science 226, 466-468.
2. Capranico, G., de Isabella, P., Penco, S., Tinelli, S. & Zunino, F. (1989) Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P 388 cells, Cancer Res. 49, 2022-2027.
3. Nelson, E. M., Tewey, K. M. & Liu, L. F. (1984) Mechanism of antitumor drug action: poisoning of mammalian DNA-topoisomeraso II by 4′-(9-acridinylamino) methanesulfon-m-anisidide, Proc. Nat. Acad. Sci. USA 81, 1361-1365.
4. Rowe, T. C., Chen, G. L., Hsiang, Y. M. & Liu, L. F. (1986) DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II, Cancer Res. 46, 2021-2026.
5. Ross, W. E., Rowe, T., Glisson, B., Yalowich, J. & Liu, L. F. (1984) Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage, Cancer Res. 44, 5857-5860.
6. Chen, G. L., Yang, L., Rowe, T., Halligan, B. D., Tewey, K. M. & Liu, L. F. (1984) Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA-topoisomerase II, J. Biol. Chem. 259, 13 560-13 566.
7. Tewey, K. M., Chen, G. L., Nelson, E. M. & Liu, L. F. (1984) Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II, J. Biol. Chem. 259, 9182-9187.
8. Liu, L. F. (1989) DNA topoisomerase poisons as antineoplastic drugs, Annu. Rev. Biochem. 58, 351-375.
9. Capranico, G., Zunino, F., Kolin, K. W. & Pommier, Y. (1990) Sequence-selective topoisomerase II inhibition by anthracycline derivatives in SV-40 DNA: relationship with DNA-binding affinity and cytotoxicity, Biochemistry 29, 562-569.
10. Sorensen, B. S., Sinding, J., Andersen, A. H., Alsner, J., Jensen, P. B. & Westergaard, O. (1992) Mode of action of topoisomerase II-targeting agents at a specific DNA sequence. Uncoupling the DNA binding, clevage, and religation events, J. Mol. Biol. 228, 778-786.
11. Paoletti, C. (1993) The localization of lopoisomerase II cleavage sites in DNA in the presence of antitumor drugs, Pharmacol. Ther. 60, 381-387.
12. Capranico, G., de Pavla, I., Tinelli, S., Bigioni, M. & Zunino, F. (1993) Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II, Biochemistry 32, 3038-3046.
13. Zwelling, L. A., Mayes, J., Hinds, M., Chan, D., Altschuler, E., Carrolii B., Parker, E., Deisseroth, K., Radcliff, A., Seligman, M., Li, L. & Farquhar, D. (1991) Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II-reactive DNA intercalative agents. Evidence for two topoisomerase II directed drug actions, Biochemistry 30, 4048-4055.
14. Deffie, A. M., Batra, J. K. & Goldenberg, G. J. (1989) Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and resistant P-388 leukemia cell lines. Cancer Res. 49, 58-62.
15. De Jong, S., Zijlstra, J. G., de Vries, E. G. E. & Mulder, N. H. (1990) Reduced DNA-topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line, Cancer Res. 50, 304-309.
16. Fernandes, D. J., Danks, M. K. & Beck, W. T. (1990) Decreased nuclear matrix DNA topoisomerase II in human leukemia cells resistant to VM-26 and m-AMSA, Biochemistry 29, 4235-4241.
17. Zwelling L. A., Hinds, M., Chan, D., Mayes, J., Sie, K. L., Parker, E., Silberman, L., Radcliffe, A., Beran, M. & Click, M. (1989) Characterization of an amsacrine-resistant line of human leukemia cells. Evidence of a drug-resistant form of topoisomerase II, J. Biol. Chem. 264, 16 411-16 420.
18. Glisson, B., Gupta, R., Smallwood-Kentro, S. & Ross, W. (1986) Characterization of a acquired epipodophyllotoxin resistance in a chinese hamster ovary cell line: loss of drug-stimulated DNA cleavage activity, Cancer Res. 46, 1934-1938.
19. Danks, M. K., Schmidt, C. A., Cirtain, M. C., Suttle, D. P. & Beck, W. T. (1988) Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26, Biochemistry 27, 8861-8869.
20. Beck, W. T., Cirtain, M. C., Danks, M. K., Felsted, R. L., Safa, A. R., Wolverton, J. S., Suttle, P. & Trent, J. M. (1987) Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells, Cancer Res. 47, 5455-5460.
21. Gottesman, M. M. & Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter, Annu. Rev. Biochem. 62, 385-427.
22. Zijlstra, J. G., de Vries, E. G. E. & Mulder, N. (1987) Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line, Cancer Res. 47, 1780-1784.
23. McGrath, T., Marquardt, D. & Center, M. S. (1989) Multiple mechanisms of adriamycin resistance in the human leukemia cell line CCRF-CEM, Biochem. Pharmacol. 38, 497-501.
24. Rabier, M. J., Bruno, N. A. & Slate, D. L. (1991) Multifactorial resistance in LSI74T human colon carcinoma cells selected with doxorubicin, Int. J. Cancer. 49, 601-607.
25. Vrignaud, P., Londos-Gagliardi, D. & Robert, J. (1986) Cellular pharmacology of doxorubicin in sensitive and resistant rat glioblastoma cell in culture, Oncology 43, 60-66.
26. Huet, S., Schott, B. & Robert, J. (1992) P-glycoprotein overexpression cannot explain the complete doxorubicin resistance phenotype in rat glioblastoma cell lines, Br. J. Cancer 65, 538-544.
27. Huet, S., Chapey, C. & Robert, J. (1993) Reversal of multidrug resistance by a new lipophilic cationic molecule, S9788: comparison with eleven other MDR-modulating agents in a model of doxorubicin-resistant rat glioblastoma cells, Eur. J. Cancer 29, 1377-1383.
28. Benchekroun, N. M., Pourquier, P., Schott, B. & Robert, J. (1993) Doxorubicin-induced lipid peroxidation and glutathione peroxidase activity in tumor cell lines selected for resistance to doxorubicin, Eur. J. Biochem. 211, 141-146.
29. Benchekroun, N. M., Sinha, B. K. & Robert, J. (1993) Doxorubicin-induced oxygen free radical formation in sensitive and doxorubicin-resistant variants of rat glioblastoma cell lines, FEBS Lett. 322, 295-298.
30. Kohn, K. W. (1991) Principles and practice of DNA filter elution, Pharmacol. Ther. 49, 55-77.
31. Trask, D. K., Di Donato, A. & Muller, T. (1984) Rapid detection and isolation of covalent DNA/protein complexes: application to topoisomerase I and II, EMBO J. 3, 671-676.
32. Kim, R. & Beck, W. T. (1994) Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression. AP-1 DNA-binding activity, and formation of JUN-FOS family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26, Cancer Res. 54, 4958-4966.
33. Drake, F. H., Zimmerman, J. P., McCabe, F. L., Bartus, H. F., Per, S. R., Sullivan, D. M., Ross, W. E., Mattern, M. R., Johnson, R. K., Crooke, S. T. & Mirabelli, C. K. (1987) Purification of topoisomerase II from amsacrine-resistant P-388 leukemia cells. Evidence for two forms of the enzyme, J. Biol. Chem. 262, 16739-16747.
34. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of head of bacteriophage T4. Nature 227, 680-685.
35. Sinha, B. K., Haim, N, Dusre, L, Kerrigan, D. & Pommier, Y. (1988) DNA strand breaks produced by etoposide (VP-16213) in sensitive and resistant human breast tumor cells: implications for the mechanism of action. Cancer Res. 48, 5096-5100.
36. Spiridonitis, C. A., Chatterjee, S., Petzold, S. J., & Berger, N. A. (1989) Topoisomerase II-dependent and -independent mechanisms of etoposide resistance in Chinese hamster cell lines. Cancer Res. 49, 644-650.
37. Ellis, A. L., Munger, C. E., Bunch, R. T., Woods, K. E., Randolph, J. K., Boise, L., Swerdlow, P. S., Zwelling, L. A., Hinds, M., Yanovich, S. & Gewirtz, D. A. (1992) Components of intrinsic drug resistance in the rat hepatoma. Biochem. Pharmacol. 43, 331-342.
38. Gewirtz, D. A. (1991) Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors? Biochem. Pharmacol. 42, 2253-2258.
39. Sinha, B. K. (1989) Free radicals in anticancer drug pharmacology, Chem. Biol. Int. 69, 293-317.
40. Keizer, H. G., Pinedo, H. M., Schuurhuis, G. J. & Joenje, H. (1990) Doxorubicin (adriamycin): a critical review of free radical-dependent mechanism of cytotoxicity, Pharmacol. Ther. 47, 219-231.
41. Spitzner, J. R., Chung, I. K., Gootz, T. D., McGuirk, P. R. & Muller, M. T. (1995) Analysis of eukaryotic topoisomerase II cleavage sites in the presence of the quinolone CP-115953 reveals drug-dependent and -independent recognition elements. Mol. Pharmacol. 48, 238-249.
42. Alsner, J. Sorensen, H. V., Scmidt, VK, Sorensen, B. S. & Westergaard, O. (1996) Topoisomerase II-mediated DNA cleavage: evidence for distinct regions of enzyme-DNA contacts, J. Mol. Biol. 259, 317-324.
43. Riou, J. F., Lefevre, D. & Riou, G. (1989) Stimulation of the topoisomerase II-indueed DNA cleavage sites in the c-myc protooncogene by antitumor drugs is associated with gene expression. Biochemistry 28, 9104-9110.
44. Pommier, Y., Orr, A., Kohn, K. W. & Riou, J. F. (1992) Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene, Cancer Res. 52, 3125-3130.
45. Riou, J. F., Gabillot, M & Riou, G. (1993) Analysis of topoisomerase II-mediated DNA cleavage of the c-myc gene during HL-60 differentiation, FEBS Lett 334, 369-372.
46. Gewirtz, D. A., Orr, M. S., Fornari, F. A., Randolph, J. K., Yalowich, J. C., Ritke, M. K., Povirk, L. F. & Bunch, R. T. (1993) Dissociation between bulk DNA damage to DNA and the antiproliferative activity of teniposide (VM-26) in the MCF-7 breast tumor cell line: evidence for induction of gene-specific damage and alterations in gene expression. Cancer Res. 53, 3547-3554.